CClinicalTrials.gg
CompletedNCT07431138Updated Feb 24, 2026

Role of Iliotibial Band Stiffness in Perceived Leg Length Discrepancy After Total Hip Arthroplasty

An observational study in Postoperative Evaluation and Arthroplasty, Replacement, Hip, sponsored by Ankara Etlik City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-02-24.

Sponsored by Ankara Etlik City Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
68
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Patients undergoing total hip arthroplasty (THA) may experience objective or perceived leg length discrepancy (LLD/PLLD), which can negatively affect gait, pelvic balance, and patient satisfaction.

The iliotibial band (ITB) plays a critical role in lateral thigh tension transmission, and alterations in its stiffness may influence the perception of limb length discrepancy.

Shear-wave elastography (SWE) is a noninvasive ultrasound-based technique that enables quantitative assessment of soft tissue stiffness.

This cross-sectional observational study aims to investigate the relationship between ITB stiffness measured by SWE and both radiographic and perceived leg length discrepancy in adult patients who underwent unilateral primary THA at least 12 months previously.

Read the detailed description

This study will include adult patients aged 18-90 years who underwent unilateral primary total hip arthroplasty at least 12 months prior to enrollment.

Patients will undergo clinical evaluation, functional scoring, radiographic assessment, and bilateral ITB stiffness measurement using shear-wave elastography.

Radiographic leg length discrepancy will be assessed using previously obtained pelvis AP and full-leg length radiographs without additional imaging exposure.

Perceived leg length discrepancy will be evaluated using a block test during standing examination.

ITB stiffness will be measured bilaterally at standardized anatomical landmarks using SWE by two experienced radiologists.

The primary aim is to assess correlations between ITB stiffness and radiographic LLD, as well as perceived LLD. Secondary analyses will evaluate whether ITB stiffness predicts PLLD independently of radiographic LLD.

02

Conditions studied

  • Postoperative Evaluation
  • Arthroplasty, Replacement, Hip
03

In context

Lead sponsor

Ankara Etlik City Hospital is the lead sponsor of 166 studies on the registry; 75 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who underwent total hip arthroplasty and had a minimum follow-up of at least 1 year were included in the study.

Inclusion criteria

Age between 18 and 90 years History of unilateral primary TKA, with no prior revision surgery At least 12 months after surgery and returned to functional weight-bearing No use of walking aids, or use of a cane only for outdoor ambulation

Exclusion criteria

Exclusion Criteria:

Bilateral TKA or severe osteoarthritis in the contralateral hip History of femoral, tibial, or hip surgery resulting in limb length-altering deformity Significant scoliosis (>20° Cobb angle) or pelvic obliquity >5° Neurological disorders (e.g., severe polyneuropathy, hemiparesis) History of lateral thigh surgery (e.g., IT band release, TFL surgery) Body mass index (BMI) >40 (may reduce the reliability of SWE measurements) Suspected prosthetic joint infection or implant instability

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
68 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • Postoperative Follow-up Cohort

    Patients who underwent surgery and were followed as part of routine postoperative care. Clinical scores and radiographic assessments were recorded during follow-up. Non-interventional ultrasound evaluation was performed in patients who had completed at least 12 months after surgery; some patients were assessed at longer postoperative intervals.

    Diagnostic Test: Shear-Wave Elastography (Ultrasound)

Interventions

  • Diagnostic testShear-Wave Elastography (Ultrasound)

    Non-interventional ultrasound performed during routine follow-up.

06

What researchers measure

Primary outcomes

  1. Harris Hip Score

    Time frame: At least 12 months postoperatively

  2. Oxford Hip Score

    Time frame: At least 12 months postoperatively

  3. HOOS score

    Hip Disability and Osteoarthritis Outcome Score

    Time frame: At least 12 months postoperatively

Secondary outcomes

  1. leg length difference

    Time frame: At least 12 months postoperatively

Other outcomes

  1. iliotibial band tension-elastogram

    Time frame: At least 12 months postoperatively

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, Yenimahalle 06170, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07431138
Lead sponsor
Ankara Etlik City Hospital
Responsible party
Sponsor
First posted
Feb 24, 2026
Start date
Jan 14, 2026
Primary completion
Feb 12, 2026
Completion
Feb 17, 2026
Last update
Feb 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion